ATRA vs BABA · rev $128.9M vs P/E 20, rev $137.30B
Atara Biotherapeutics Inc (ATRA) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
ATRA currently screens at market cap $87.1M. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the ATRA and BABA stock pages for the full models.
Not investment advice.